NRSN Stock Analysis: Buy, Sell, or Hold?
NRSN - NeuroSense Therapeutics Ltd. Ordinary Shares
$0.92
-0.03 (-3.15%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When NRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called NRSN this week
75% bullish • 1 bearish
75% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
ℹ️ NEUTRAL: NRSN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
ℹ️ NEUTRAL: NRSN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NRSN is currently trading at $0.92, which is considered fair relative to its 30-day fair value range of $0.81 to $1.02.
Technical Outlook: Technically, NRSN is in a strong downtrend. Immediate support is located at $0.86, while resistance sits at $1.08. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: NRSN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.50 (+1150.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRSN is in a strong downtrend. Immediate support is located at $0.86, while resistance sits at $1.08. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: NRSN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.50 (+1150.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.81 -
$1.02
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 1150.0% below Wall St target ($11.50)
Fair Price Analysis
30-Day Fair Range
$0.81 -
$1.02
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.86
Resistance Level
$1.08
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.11
Wall Street Target
$11.50
(+1150.0%)
Last updated: February 01, 2026 7:09 PM ET
Data refreshes hourly during market hours. Next update: 8:09 PM
Data refreshes hourly during market hours. Next update: 8:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
